Plexus stock price target lowered to $158 by Needham on mixed outlook

Plexus (PLXS) reported strong fiscal Q3 EPS of $1.90, exceeding expectations, though revenue of $1.018 billion slightly missed consensus. Despite robust financial health indicated by a perfect Piotroski Score of 9 and strong free cash flow, the stock declined 12.2% last week, reflecting mixed analyst sentiment. Needham lowered its price target to $158 while maintaining a Buy rating, citing positive demand outlook for fiscal 2026 despite Q4 revenue guidance falling below Street expectations. This contrasts with Raymond James reiterating an Outperform rating with a $165 target, while Stifel lowered its target to $140 with a Hold rating, highlighting ongoing investor debate regarding the company's revenue trajectory.

Analysis

Plexus Corp. (PLXS) presents a conflicting investment profile, marked by strong current profitability and fundamentals against a weak near-term revenue outlook. The company's fiscal third-quarter non-GAAP earnings per share of $1.90 surpassed consensus by 11%, driven by robust gross and operating margins, lower interest expenses, and a favorable tax rate, rather than top-line strength, as revenue of $1.018 billion was merely in line. The firm's financial health appears solid, evidenced by a perfect Piotroski Score of 9, an attractive 11% free cash flow yield, and a low PEG ratio of 0.41, suggesting potential undervaluation. However, this is overshadowed by its fiscal fourth-quarter guidance, where the revenue midpoint projects a 0.5% year-over-year decline, starkly contrasting with analyst expectations of 3% growth. This weak forward guidance has likely contributed to the stock's recent 12.2% decline and has created a clear divergence in analyst sentiment, with Needham and Raymond James maintaining bullish ratings based on the fiscal 2026 outlook, while Stifel holds a more cautious stance due to the mixed forecast.

Key Decisions for Investors

• The recent 12.2% stock price decline, combined with strong fundamental indicators like a perfect Piotroski Score and an 11% free cash flow yield, may present a compelling entry point for value-focused investors with a long-term perspective.
• Investors should closely monitor the company's revenue trajectory in the coming quarters to validate whether the weak Q4 guidance is a temporary issue or the beginning of a more persistent slowdown, as this is the primary point of analyst contention.
• Given the conflicting analyst price targets ($140 to $165) and the cautious forward guidance, it is prudent to weigh the attractive valuation, indicated by a 0.41 PEG ratio, against the tangible risk of near-term top-line underperformance before increasing a position.